Search for dissertations about: "DLBCL"
Showing result 6 - 10 of 44 swedish dissertations containing the word DLBCL.
-
6. Diffuse large B-cell lymphoma – studies on immunohistochemical and clinical prognostic factors
Abstract : DLBCL, the most common lymphoma entity, is a potentially curable but heterogeneous disease. Most studies concerning therapy and prognostic factors have been performed on selected patient materials. It is important to identify immunohistochemical biomarkers which could add prognostic information to clinical factors. READ MORE
-
7. Prognostic Markers and Mechanisms of Chemotherapy Resistance in Diffuse Large B-cell Lymphoma
Abstract : Diffuse large B-cell lymphoma (DLBCL) is an aggressive and heterogeneous disease. Identification of prognostic and predictive markers is important to design individualised and effective treatment strategies. READ MORE
-
8. Molecular Characterization of Diffuse Large B-cell Lymphoma and Aspects of Transformation
Abstract : Lymphomas are a heterogeneous group of neoplasias originating from B- or T-lymphocytes. In this thesis, we determined the genetic and immunophenotypic characterization of DLBCL and their prognostic impact. READ MORE
-
9. Characterization of the genome and tumor microenvironment of human B-cell lymphoma
Abstract : Non-Hodgkin lymphoma (NHL) is the 13th most common type of cancer worldwide in 2020 and consists mainly of human B-cell lymphoma (approximately 85%). Diffuse large B-cell lymphoma (DLBCL) is the most common NHL subtype (approximately 30%). READ MORE
-
10. Diffuse large B-cell lymphoma - tumour characteristics on RNA and protein level associated with prognosis
Abstract : Diffuse large B-cell lymphoma (DLBCL) is the most frequent lymphoma subtype. In Sweden 450 new cases are diagnosed annually. With modern anthracycline-containing chemotherapy DLBCL is potentially curable, with an estimated overall cure rate of approximately 50% for patients with advanced stage disease. READ MORE